Lin, C., Verma, V., Lazenby, A., Ly, Q. P., Berim, L. D., Schwarz, J. K., . . . Grem, J. L. (2019). Phase I/II Trial of Neoadjuvant Oregovomab-Based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir for Locally Advanced Pancreatic Adenocarcinoma. Am J Clin Oncol.
Citação norma ChicagoLin, Chi, et al. "Phase I/II Trial of Neoadjuvant Oregovomab-Based Chemoimmunotherapy Followed By Stereotactic Body Radiotherapy and Nelfinavir for Locally Advanced Pancreatic Adenocarcinoma." Am J Clin Oncol 2019.
Citação norma MLALin, Chi, et al. "Phase I/II Trial of Neoadjuvant Oregovomab-Based Chemoimmunotherapy Followed By Stereotactic Body Radiotherapy and Nelfinavir for Locally Advanced Pancreatic Adenocarcinoma." Am J Clin Oncol 2019.